Responses to des-Arg'-bradykinin, a selective kinin Bi receptor agonist, were characterized in the pulmonary vascular bed of the intact-chest cat. Injections of des-Arg'-bradykinin into the perfused lobar artery under low-resting tone conditions caused dose-related increases in lobar arterial pressure; whereas in the same experiment under elevated tone responses under elevated-tone conditions were inhibited by N'-nitro-L-arginine methyl ester, suggesting that des-Arg'-bradykinin stimulates the release of nitric oxide, whereas meclofenamate and U-37883A, a nonsulfonylurea ATP-sensitive K' channel antagonist, did not alter vasodilator responses to the Bi receptor agonist. These results suggest that vasoconstrictor responses to des-Arg'-bradykinin under low-tone conditions are mediated by the activation of kinin Bi receptors, the release of catecholamines within the lung, and the activation of a-adrenergic receptors, whereas vasodilator responses under elevated tone conditions are mediated by activation of Bi receptors and the release of nitric oxide from the endothelium. These data provide pharmacologic evidence for the existence of functionally active kinin Bi receptors that mediate tone-dependent vasoconstrictor and vasodilator responses in the pulmonary vascular bed of the cat. (Circ Res. 1994;75:1064-1072 Key Words * des-Arg9-bradykinin * Hoe 140 * pulmonary vascular bed * kinin Bi receptor * nitric oxideThere is considerable pharmacologic evidence in support of the concept of BK receptor heterogeneity.2'3'13'14The classic BK receptor subtypes have been characterized as B1 and B2, and the action of BK on the B2 receptor is thought to mediate the majority of physiological responses to the kinins.23 The Bi receptor is selectively stimulated by DABK on the basis of highaffinity contractile activity of the peptide in the rabbit aorta, mesenteric vein, and basilar artery; however, this receptor is not believed to play an important role under physiological conditions.314 The development of competitive, potent, selective kinin receptor antagonists has provided support for the identity of Bi receptors.2'3 DABK does not activate B2 receptors but stimulates kinin B1 receptors, and a change in the balance between levels of BK and its metabolite, DABK, could change the emphasis and effects of the kinin system.23"15Although Bi receptors are not thought to be physiologically important in mediating cardiovascular responses to kinins, such as increased vascular permeability, smooth muscle contraction, vasodilation, and hypotension, they have recently been shown to play a role in mediating decreases in systemic arterial pressure in the dog under physiological conditions.'6-19 Kinin